Phase II trial of gemcitabine, epirubicin, and G-CSF in patients with metastatic pancreatic cancer

被引：0
|
作者：
Raderer, M
Kornek, GV
Valencak, J
Lenauer, A
Flebiger, W
Greul, R
Lang, F
Schneeweiss, B
Depisch, D
Scheithauer, W
机构：
[1] Univ Vienna, Dept Internal Med 1, A-1010 Vienna, Austria
[2] AoKH Kirchdorf Krems, Dept Internal Med, Krems, Austria
[3] Wr Neustadt, Dept Surg, Vienna, Austria
[4] Neunkirchen Gen Hosp, Dept Surg, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
648
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [1] Final results of gemcitabine (G) and epirubicin (E) phase II trial in metastatic breast cancer (MBC) patients (pts).
    Fumoleau, P
    Viens, P
    Dieras, V
    Pujade-Lauraine, E
    Serin, D
    Petit, T
    Espie, M
    Kayitalire, L
    Robert, C
    Pouillart, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S90 - S90
  • [2] Gemcitabine (G) combined with gefitinib in patients with inoperable or metastatic pancreatic cancer. A phase II trial
    Fountzilas, G.
    Murray, S.
    Xiros, N.
    Karayannopoulou, G.
    Dafni, U.
    Linardou, H.
    Kalogera-Fountzila, A.
    Bobos, M.
    Koumarianou, A.
    Kosmidis, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial
    Ianniello, GP
    Orditura, M
    Rossi, A
    De Vita, F
    Maiorino, L
    Carrozza, F
    Manzione, L
    Catalano, G
    ONCOLOGY REPORTS, 2001, 8 (05) : 1111 - 1115
  • [4] Phase I/II trial of Gemcitabine and Epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Riemann, JF
    GASTROENTEROLOGY, 2002, 122 (04) : A493 - A493
  • [5] Phase I/II trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A
    Jakobs, R
    Martin, WR
    Eickhoff, JC
    Riemann, JF
    GASTROENTEROLOGY, 2005, 128 (04) : A432 - A432
  • [6] Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
    Van Cutsem, Eric
    Hidalgo, Manuel
    Canon, Jean-Luc
    Macarulla, Teresa
    Bazin, Igor
    Poddubskaya, Elena
    Manojlovic, Nebojsa
    Radenkovic, Dejan
    Verslype, Chris
    Raymond, Eric
    Cubillo, Antonio
    Schueler, Armin
    Zhao, Charles
    Hammel, Pascal
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (08) : 2053 - 2064
  • [7] Gemcitabine and epirubicin in patients with metastatic breast cancer:: A phase I/II study
    Campone, Mario
    Fumoleau, Pierre
    Viens, Patrice
    Dieras, Wronique
    Pujade-Lauraine, Eric
    Serin, Daniel
    Petit, Thierry
    Espie, Marc
    Kayitalire, Louis
    Bozec, Laurence
    Pouillart, Pierre
    BREAST, 2006, 15 (05): : 601 - 609
  • [8] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [9] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A.
    Martin, W.
    Hartmann, D.
    Eickhoff, J. C.
    Moehler, M.
    Galle, P. R.
    Riemann, J. F.
    Jakobs, R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1572 - 1574
  • [10] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    A Eickhoff
    W Martin
    D Hartmann
    J C Eickhoff
    M Möhler
    P R Galle
    J F Riemann
    R Jakobs
    British Journal of Cancer, 2006, 94 : 1572 - 1574
12345